These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 31563809)

  • 21. Anti biofilm effect of dihydromyricetin-loaded nanocapsules on urinary catheter infected by Pseudomonas aeruginosa.
    Dalcin AJF; Santos CG; Gündel SS; Roggia I; Raffin RP; Ourique AF; Santos RCV; Gomes P
    Colloids Surf B Biointerfaces; 2017 Aug; 156():282-291. PubMed ID: 28544960
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Optimization of colistin dosing regimen for cystic fibrosis patients with chronic Pseudomonas aeruginosa biofilm lung infections.
    Hengzhuang W; Green K; Pressler T; Skov M; Katzenstein TL; Wu X; Høiby N
    Pediatr Pulmonol; 2019 May; 54(5):575-580. PubMed ID: 30803159
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tailored Nanocarriers for the Pulmonary Delivery of Levofloxacin against Pseudomonas aeruginosa: A Comparative Study.
    Derbali RM; Aoun V; Moussa G; Frei G; Tehrani SF; Del'Orto JC; Hildgen P; Roullin VG; Chain JL
    Mol Pharm; 2019 May; 16(5):1906-1916. PubMed ID: 30900903
    [TBL] [Abstract][Full Text] [Related]  

  • 24. PLGA-Based Nanoplatforms in Drug Delivery for Inhibition and Destruction of Microbial Biofilm.
    Shariati A; Chegini Z; Ghaznavi-Rad E; Zare EN; Hosseini SM
    Front Cell Infect Microbiol; 2022; 12():926363. PubMed ID: 35800390
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bacteriophage PEV20 and Ciprofloxacin Combination Treatment Enhances Removal of Pseudomonas aeruginosa Biofilm Isolated from Cystic Fibrosis and Wound Patients.
    Chang RYK; Das T; Manos J; Kutter E; Morales S; Chan HK
    AAPS J; 2019 Apr; 21(3):49. PubMed ID: 30949776
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis and self-assembly of curcumin-modified amphiphilic polymeric micelles with antibacterial activity.
    Barros CHN; Hiebner DW; Fulaz S; Vitale S; Quinn L; Casey E
    J Nanobiotechnology; 2021 Apr; 19(1):104. PubMed ID: 33849570
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Alginate lyase immobilized chitosan nanoparticles of ciprofloxacin for the improved antimicrobial activity against the biofilm associated mucoid P. aeruginosa infection in cystic fibrosis.
    Patel KK; Tripathi M; Pandey N; Agrawal AK; Gade S; Anjum MM; Tilak R; Singh S
    Int J Pharm; 2019 May; 563():30-42. PubMed ID: 30926526
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 3,6-Di(pyridin-2-yl)-1,2,4,5-tetrazine (pytz)-capped silver nanoparticles (TzAgNPs) inhibit biofilm formation of Pseudomonas aeruginosa: a potential approach toward breaking the wall of biofilm through reactive oxygen species (ROS) generation.
    Chakraborty P; Joardar S; Ray S; Biswas P; Maiti D; Tribedi P
    Folia Microbiol (Praha); 2018 Nov; 63(6):763-772. PubMed ID: 29855854
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fabrication of inhaled hybrid silver/ciprofloxacin nanoparticles with synergetic effect against Pseudomonas aeruginosa.
    Al-Obaidi H; Kalgudi R; Zariwala MG
    Eur J Pharm Biopharm; 2018 Jul; 128():27-35. PubMed ID: 29654885
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of methicillin-resistant
    Qiu Y; Wu Y; Lu B; Zhu G; Gong T; Wang R; Peng Q; Li Y
    Biofouling; 2020 Feb; 36(2):159-168. PubMed ID: 32182142
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nano-antibiotics in chronic lung infection therapy against Pseudomonas aeruginosa.
    Hadinoto K; Cheow WS
    Colloids Surf B Biointerfaces; 2014 Apr; 116():772-85. PubMed ID: 24656614
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Novel Inhaled Combination Powder Containing Amorphous Colistin and Crystalline Rifapentine with Enhanced Antimicrobial Activities against Planktonic Cells and Biofilm of Pseudomonas aeruginosa for Respiratory Infections.
    Zhou QT; Sun SP; Chan JG; Wang P; Barraud N; Rice SA; Wang J; Li J; Chan HK
    Mol Pharm; 2015 Aug; 12(8):2594-603. PubMed ID: 25423590
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Externally controlled triggered-release of drug from PLGA micro and nanoparticles.
    Hua X; Tan S; Bandara HM; Fu Y; Liu S; Smyth HD
    PLoS One; 2014; 9(12):e114271. PubMed ID: 25479357
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy of Poly-Lactic-Co-Glycolic Acid Micro- and Nanoparticles of Ciprofloxacin Against Bacterial Biofilms.
    Thomas N; Thorn C; Richter K; Thierry B; Prestidge C
    J Pharm Sci; 2016 Oct; 105(10):3115-3122. PubMed ID: 27519649
    [TBL] [Abstract][Full Text] [Related]  

  • 35. PEGylation of Tobramycin Improves Mucus Penetration and Antimicrobial Activity against Pseudomonas aeruginosa Biofilms in Vitro.
    Bahamondez-Canas TF; Zhang H; Tewes F; Leal J; Smyth HDC
    Mol Pharm; 2018 Apr; 15(4):1643-1652. PubMed ID: 29514003
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Micro/nanosystems and biomaterials for controlled delivery of antimicrobial and anti-biofilm agents.
    Bianchera A; Buttini F; Bettini R
    Expert Opin Ther Pat; 2020 Dec; 30(12):983-1000. PubMed ID: 33078643
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Biopolymer nanogels improve antibacterial activity and safety profile of a novel lysine-based α-peptide/β-peptoid peptidomimetic.
    Kłodzińska SN; Molchanova N; Franzyk H; Hansen PR; Damborg P; Nielsen HM
    Eur J Pharm Biopharm; 2018 Jul; 128():1-9. PubMed ID: 29605468
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Facile green synthesis of baicalein fabricated gold nanoparticles and their antibiofilm activity against Pseudomonas aeruginosa PAO1.
    Rajkumari J; Busi S; Vasu AC; Reddy P
    Microb Pathog; 2017 Jun; 107():261-269. PubMed ID: 28377235
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment with the Pseudomonas aeruginosa Glycoside Hydrolase PslG Combats Wound Infection by Improving Antibiotic Efficacy and Host Innate Immune Activity.
    Pestrak MJ; Baker P; Dellos-Nolan S; Hill PJ; Passos da Silva D; Silver H; Lacdao I; Raju D; Parsek MR; Wozniak DJ; Howell PL
    Antimicrob Agents Chemother; 2019 Jun; 63(6):. PubMed ID: 30988141
    [No Abstract]   [Full Text] [Related]  

  • 40. Explorative gene analysis of antibiotic tolerance-related genes in adherent and biofilm cells of Pseudomonas aeruginosa.
    Murakami K; Ono T; Noma Y; Minase I; Amoh T; Irie Y; Hirota K; Miyake Y
    J Infect Chemother; 2017 May; 23(5):271-277. PubMed ID: 28274550
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.